Pegol-Sihematide

Pegol-Sihematide · Jiangsu Hansoh Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Pegol-Sihematide, covering 2022-09-01 to 2023-03-09. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Efficacy and Safety of Pegol-Sihematide for Anemia in Patients With Chronic Kidney Disease on Dialysis [Phase 3]

See pricing